top of page
Choose your experience:
You are viewing content for pharmacists & providers. Click here to view information for patients & advocates.
You are viewing information for patients & advocates. Click here to view pharmacist & provider content.
news articles


Hy-Vee Pharmacies Now Offer Talking Prescription Labels in 26 Languages
Hy-Vee Pharmacies Now Offer Talking Prescription Labels in 26 Languages to Assist Visually- and Print-Impaired Patients.
Dec 17, 20213 min read


How To Use The ScripTalk Mobile App
In this video, you’ll learn how to use the FREE ScripTalk Mobile App to speak the information contained on your medication labels.
Oct 11, 20211 min read


Perseverance Pays Off for 25-Year-Old Company
Dave Raistrick and his father Phil designed En-Vision America as a way to provide support for those with vision impairment.
Oct 4, 20211 min read


Suncoast Company En-Vision America Helps Vision Impaired Gain Independence
An ABC Sarasota 7 news anchor recently interviewed the En-Vision America team.
Sep 3, 20211 min read


It All Started With a Vision: Featuring David Raistrick
Learn what inspires and drives our team to continuously evolve and improve our products and services.
Sep 3, 20211 min read
news articles


Fox News Covers En-Vision America's Expansion & Ribbon Cutting
En-Vision America's Celebration of 30 Years Continues. Fox News’ Kimberly Kuizon recently visited us to tell our story, and we couldn’t be more proud!! Hear what she has to say … Click here to read the full article by Fox 13 News.
En-Vision America


ScripTalk Patient Interview: Moe's Challenges
Moe’s journey is a story of resilience. From immigrating to the U.S. from Iran to adapting to vision loss, he now uses assistive technology to stay independent — including Talking Prescription Labels.
En-Vision America


ScripTalk Patient Interview: Terri's Story
Terri cannot read prescription labels and accidentally took her dog’s heartworm medication. ScripTalk Talking Labels now help to ensure her safety.
En-Vision America
bottom of page















